'Denosumab' presentation slideshows

221 views • 21 slides

0.6

Vert. Non-Vert. Hip. Avoid direct comparisons of efficacy as treatments are not tested in comparator trials. RIS 5 (VERT-NA). RIS 5 (VERT-MN). RIS 2.5/5 (Hip Study). Strontium ranelate (SOTI) 1. **. (TROPOS ) 2. ** Subgroup/ post hoc analysis.

138 views • 13 slides

0.6

Vert. Non-Vert. Hip. Avoid direct comparisons of efficacy as treatments are not tested in comparator trials. RIS 5 (VERT-NA). RIS 5 (VERT-MN). RIS 2.5/5 (Hip Study). Strontium ranelate (SOTI) 1. **. (TROPOS ) 2. ** Subgroup/ post hoc analysis.

134 views • 13 slides

Authors: Fizazi K et al, ASCO 2010 Abstract: LBA4507 Reviewed by: Dr. Lori Wood

A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer (CRPC). Authors: Fizazi K et al, ASCO 2010 Abstract: LBA4507 Reviewed by: Dr. Lori Wood Date posted: Jun 18 2010.

180 views • 7 slides